NNNN - צמיחת מכירות משנה לשנה ב-12 החודשים האחרונים Anbio Corp

Anbio Biotechnology is implementing autonomous biomaterial screening systems, which accelerates data interpretation. This chart of annual sales growth over the TTM confirms this progress, and the value of 10.10 shows the latest metric value. Anbio Biotechnology generates revenue from the supply of portable analyzers and reagents, leveraging the demand for compact POCT solutions and flexible pricing power within the rapid diagnostics segment.
Anbio (NNNN) - פילוחי מדדים ודוחות פיננסיים

Anbio Biotechnology is optimizing its scaling through the outsourcing of reagent production, minimizing operational risks during demand spikes. The effectiveness of this strategy is reflected in the LTM sales growth YoY. This metric compares revenue over the last twelve months with the same prior period, revealing the actual pace of business expansion. A decline in this curve amid rising share prices signals an asset overvaluation and the risk of a capital correction.